Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21
Pediatrix Medical Group (NYSE: MD) has announced NEO: The Conference for Neonatology, a major educational event scheduled for Feb. 19-21 in Las Vegas. The conference aims to advance neonatology by bringing together neonatologists, pediatricians, and healthcare professionals globally.
The announcement comes as the March of Dimes' 2024 Report Card reveals concerning statistics about preterm births in the United States. The nation's preterm birth rate remains at a historic high of 10.4%, with 370,000 premature births in 2023, only slightly lower than the 10.5% rate in 2022. The U.S. received a D+ grade for the third consecutive year.
As a leading provider of neonatology services for over 45 years, Pediatrix currently cares for nearly 25% of U.S. infants requiring intensive care. Dr. Timothy Biela, conference director and neonatologist at Pediatrix Neonatology of San Antonio, emphasizes the critical need for continuous innovation in neonatal-perinatal medicine to improve outcomes for vulnerable patients.
Pediatrix Medical Group (NYSE: MD) ha annunciato NEO: La Conferenza per la Neonatologia, un importante evento formativo in programma dal 19 al 21 febbraio a Las Vegas. L'obiettivo della conferenza è quello di far avanzare la neonatologia riunendo neonatologi, pediatri e professionisti della salute a livello globale.
L'annuncio arriva mentre il Rapporto 2024 di March of Dimes rivela statistiche preoccupanti sui parti prematuri negli Stati Uniti. Il tasso di nascita prematura nel paese rimane ai massimi storici del 10,4%, con 370.000 nascite premature nel 2023, solo leggermente inferiore al tasso del 10,5% del 2022. Gli Stati Uniti hanno ricevuto un voto di D+ per il terzo anno consecutivo.
Come fornitore leader di servizi di neonatologia da oltre 45 anni, Pediatrix attualmente si prende cura di quasi il 25% dei neonati statunitensi che necessitano di cure intensive. Il Dr. Timothy Biela, direttore della conferenza e neonatologo presso Pediatrix Neonatology di San Antonio, sottolinea l'importanza critica dell'innovazione continua nella medicina neonatale-perinatale per migliorare i risultati per i pazienti vulnerabili.
Pediatrix Medical Group (NYSE: MD) ha anunciado NEO: La Conferencia de Neonatología, un importante evento educativo programado del 19 al 21 de febrero en Las Vegas. La conferencia tiene como objetivo avanzar en la neonatología reuniendo a neonatólogos, pediatras y profesionales de la salud de todo el mundo.
El anuncio llega mientras el Informe 2024 de March of Dimes revela estadísticas preocupantes sobre los nacimientos prematuros en los Estados Unidos. La tasa de nacimientos prematuros en el país se mantiene en un nivel histórico alto de 10.4%, con 370,000 nacimientos prematuros en 2023, solo ligeramente inferior a la tasa de 10.5% en 2022. Estados Unidos recibió una calificación de D+ por tercer año consecutivo.
Como proveedor líder de servicios de neonatología durante más de 45 años, Pediatrix actualmente atiende a casi el 25% de los bebés estadounidenses que requieren cuidados intensivos. El Dr. Timothy Biela, director de la conferencia y neonatólogo en Pediatrix Neonatology de San Antonio, enfatiza la necesidad crítica de innovación continua en la medicina neonatal-perinatal para mejorar los resultados de los pacientes vulnerables.
Pediatrix Medical Group (NYSE: MD)가 2월 19일부터 21일까지 라스베가스에서 열리는 주요 교육 행사인 NEO: 신생아학 회의를 발표했습니다. 이 회의는 전세계의 신생아학자, 소아과 의사 및 의료 전문가들이 모여 신생아학을 발전시키는 것을 목적으로 하고 있습니다.
이번 발표는 March of Dimes 2024 보고서가 미국의 조산에 대한 우려스러운 통계들을 공개하면서 이루어졌습니다. 미국의 조산율은 역사적 최고치인 10.4%를 유지하고 있으며, 2023년에 370,000건의 조산이 발생했으며, 이는 2022년의 10.5%에 비해 약간 낮은 수치입니다. 미국은 3년 연속 D+ 등급을 받았습니다.
45년 이상 신생아학 서비스를 제공해온 Pediatrix는 현재 미국에서 집중 치료가 필요한 영아의 거의 25%를 돌보고 있습니다. 회의 책임자이자 Pediatrix Neonatology에서 신생아학자인 Dr. Timothy Biela는 취약한 환자의 결과를 개선하기 위해 신생아-주산의학 분야에서 지속적인 혁신의 중요성을 강조합니다.
Pediatrix Medical Group (NYSE: MD) a annoncé NEO : La Conférence sur la Néonatologie, un événement éducatif majeur prévu du 19 au 21 février à Las Vegas. La conférence vise à faire avancer la néonatologie en réunissant des néonatologues, des pédiatres et des professionnels de la santé du monde entier.
L'annonce intervient alors que le Rapport 2024 de March of Dimes révèle des statistiques préoccupantes concernant les naissances prématurées aux États-Unis. Le taux de naissances prématurées du pays demeure à un niveau historiquement élevé de 10,4%, avec 370 000 naissances prématurées en 2023, légèrement inférieur au taux de 10,5% en 2022. Les États-Unis ont reçu une note de D+ pour la troisième année consécutive.
En tant que fournisseur leader de services de néonatologie depuis plus de 45 ans, Pediatrix prend actuellement soin de près de 25% des nourrissons américains nécessitant des soins intensifs. Le Dr Timothy Biela, directeur de la conférence et néonatologiste chez Pediatrix Neonatology de San Antonio, souligne la nécessité cruciale d'innovation continue en médecine néonatale-périnatale pour améliorer les résultats pour les patients vulnérables.
Pediatrix Medical Group (NYSE: MD) hat die NEO: Die Konferenz für Neonatologie angekündigt, eine wichtige Bildungsveranstaltung, die vom 19. bis 21. Februar in Las Vegas stattfindet. Die Konferenz hat zum Ziel, die Neonatologie voranzubringen, indem Neonatologen, Kinderärzte und Gesundheitsfachkräfte weltweit zusammengebracht werden.
Die Ankündigung erfolgt, nachdem der 2024 Bericht von March of Dimes besorgniserregende Statistiken über Frühgeburten in den Vereinigten Staaten offenbart. Die Frühgeburtenrate des Landes bleibt mit 10,4% auf einem historisch hohen Niveau, mit 370.000 Frühgeburten im Jahr 2023, was nur leicht niedriger ist als die Quote von 10,5% im Jahr 2022. Die USA erhielten zum dritten Mal in Folge eine Note von D+.
Als führender Anbieter von Neonatologiediensten seit über 45 Jahren betreut Pediatrix derzeit fast 25% der in den USA intensivpflegebedürftigen Säuglinge. Dr. Timothy Biela, Konferenzdirektor und Neonatologe bei Pediatrix Neonatology in San Antonio, betont die kritische Notwendigkeit kontinuierlicher Innovationen in der neonatologischen-perinatalen Medizin, um die Ergebnisse für gefährdete Patienten zu verbessern.
- None.
- None.
As the preterm birth rate remains at an all-time high, continuing education for providers of neonatal intensive care is critical
As a trusted provider of neonatology services for more than 45 years, Pediatrix cares for nearly a quarter of the infants born in
The March of Dimes’ 2024 Report Card, released in November, reported that the nation’s preterm birth rate remains historically high at
“These findings emphasize the need for continuous innovation in the field of neonatal-perinatal medicine,” said Timothy Biela, M.D., neonatologist at Pediatrix Neonatology of
About the Conference
Now in its 46th year, the NEO conference addresses the latest advancements, research and best practices in neonatology. The meeting aims to provide a platform for knowledge exchange, professional development and collaboration among health care professionals dedicated to the care of newborns.
The comprehensive program includes:
- Plenary sessions on cutting-edge research and clinical practices
- Interactive workshops and hands-on training sessions
- Panel discussions with industry experts and thought leaders
- Networking opportunities with peers and leaders in neonatology
- Exhibits showcasing the latest technologies and products in neonatal care
Keynote Speakers
The NEO conference will feature an impressive lineup of keynote speakers, including renowned experts in the field of neonatology. Among the distinguished speakers are:
- Dan Ellsbury, M.D., Director of Quality and Safety for Neonatology, the Pediatrix Center for Research, Education, Quality and Safety (CREQS)
-
Elizabeth Foglia, M.D., MSCE, Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine | Children’s Hospital of
Philadelphia - Haresh Kirpalani, M.D., Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine
-
Josef Neu, M.D., Professor of Pediatrics, University of
Florida College of Medicine - Noelle Younge, M.D., MHS, Jean and George W. Brumley, Jr., M.D., Assistant Professor of Pediatrics, Duke University School of Medicine
- Robert Ursprung, M.D., MMSc, Director of Quality and Safety for Neonatology, the Pediatrix CREQS
These thought leaders will share their insights on groundbreaking research, innovative treatments and emerging trends in neonatal care.
Legends of Neonatology
Established in 2007, the Legends of Neonatology award honors remarkable individuals whose clinical contributions have helped forge new ground in neonatal medicine. This year’s recipient is David K. Stevenson, M.D., Harold K. Faber Professor of Pediatrics, Senior Associate Dean for Maternal and Child Health at the Stanford University School of Medicine and Principal Investigator of the Prematurity Research Center. Over the span of four decades, Dr. Stevenson has been at the forefront of research, professional education and clinical care in neonatology. He has made pioneering contributions to neonatology and pediatrics through extensive research in bilirubin biochemistry, heme oxygenase biology and neonatal jaundice. His work has led to new technologies and standards of care for the treatment of neonatal jaundice.
Accredited Continuing Education
Participants attending the NEO conference will have the opportunity to earn accredited continuing education credits. The Pediatrix CREQS is accredited by:
- The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians, designating this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™.
- The American Nurses Credentialing Center’s Commission on Accreditation as a provider of nursing continuing professional development, designating this live activity for a maximum of 20.25 nursing contact hour(s).
About Pediatrix Medical Group
Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,400 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211765616/en/
For media inquiries, please contact:
Jennifer Gutierrez, Corporate Communications
jennifer.gutierrez@pediatrix.com
954.384.0175 ext. 5684
Source: Pediatrix Medical Group, Inc.
FAQ
When and where is Pediatrix Medical Group (MD) hosting the NEO Conference 2024?
What percentage of U.S. preterm births were reported in 2023 according to March of Dimes?
What percentage of U.S. infants requiring intensive care does Pediatrix (MD) treat?
What grade did the U.S. receive in the March of Dimes 2024 Report Card?
How long has Pediatrix Medical Group (MD) been providing neonatology services?
